NCT04047407 is a clinical trial of Suprathreshold pain stimulation in Fibromyalgia, sponsored by University of Castilla-La Mancha.

Who is sponsoring NCT04047407?

NCT04047407 is sponsored by University of Castilla-La Mancha.

What drugs are being tested in NCT04047407?

Interventions in NCT04047407: Suprathreshold pain stimulation.

What condition does NCT04047407 study?

NCT04047407 studies Fibromyalgia.

Is NCT04047407 still recruiting?

NCT04047407 is currently status unknown. Last updated 6 August 2019.

Last reviewed 2019-08-06 · How we verify

NCT04047407

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Suprathreshold Pressure Pain Stimulation in Fibromyalgia

Status unknown Last updated 6 August 2019

What this trial tests

trial testing Suprathreshold pain stimulation in Fibromyalgia in 52 participants. Status unknown.

Timeline

3 June 2019

Primary endpoint
18 September 2019

18 September 2019

Quick facts

Lead sponsor	University of Castilla-La Mancha
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	52
Start date	3 June 2019
Primary completion	18 September 2019
Estimated completion	18 September 2019
Sites	1 location across Spain

Drugs / interventions tested

Suprathreshold pain stimulation

Conditions studied

Fibromyalgia — all drugs for Fibromyalgia →

Sponsor

University of Castilla-La Mancha

Who can join

Adults 18 to 80, any sex, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the induced-pain characteristics after suprathreshold pressure stimulation at different intensities in fibromyalgia subjects, compared with healthy volunteers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
NCT07245303 — Neural Mechanisms of Light Driven Analgesia · NA · recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
NCT07465991 — The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia · NA · recruiting

Other University of Castilla-La Mancha trials

Trials by the same sponsor.

NCT07487857 — Intensive Somatosensory Camp for Manual Function and Participation in Children With Unilateral Cerebral Palsy · NA · not yet recruiting
NCT07419035 — Bipolar Radiofrequency for Genitourinary Syndrome of Menopause · NA · not yet recruiting
NCT07452172 — Lumbar and Gluteal Motor Control in Chronic Low Back Pain · NA · not yet recruiting
NCT07041944 — HEMImprove 1.0 in Children and Adolescents With Unilateral Cerebral Palsy · NA · not yet recruiting
NCT07091461 — HOMe-IMprove Telerrehabilitation System · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04047407 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Castilla-La Mancha
Last refreshed: 6 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04047407.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing